https://www.selleckchem.com/pr....oducts/navoximod.htm
Objectives This is a first-in-human study of the PET radiotracer 11C-LSN3172176 for the muscarinic acetylcholine receptor subtype 1 (M1). The objectives of this study were to determine the appropriate kinetic model to quantify the tracer's binding to M1 receptors, and the reliability of the chosen quantification method. Methods Six healthy subjects completed the test-retest protocol and five healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate volume of distribution